![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of B4GALT4 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of B4GALT4 mRNA | CTD | PMID:22206623 | 2-methylcholine | affects expression | ISO | RGD:1317330 | 6480464 | beta-methylcholine affects the expression of B4GALT4 mRNA | CTD | PMID:21179406 | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | RGD:1307880 | 6480464 | 3 more ... | CTD | PMID:23196670 | 4,4'-diaminodiphenylmethane | affects expression | EXP | | 6480464 | 4, 4'-diaminodiphenylmethane affects the expression of B4GALT4 mRNA | CTD | PMID:18648102 | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of B4GALT4 mRNA | CTD | PMID:28973697 | acrolein | multiple interactions | ISO | RGD:1317330 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B4GALT4 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B4GALT4 mRNA | CTD | PMID:32699268 | alpha-pinene | multiple interactions | ISO | RGD:1317330 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B4GALT4 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B4GALT4 mRNA | CTD | PMID:32699268 | aristolochic acid | decreases expression | ISO | RGD:1317330 | 6480464 | aristolochic acid I results in decreased expression of B4GALT4 mRNA | CTD | PMID:33212167 | Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of B4GALT4 mRNA | CTD | PMID:23650126 | benzo[a]pyrene | decreases methylation | ISO | RGD:1317330 | 6480464 | Benzo(a)pyrene results in decreased methylation of B4GALT4 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | RGD:1317330 | 6480464 | Benzo(a)pyrene results in increased methylation of B4GALT4 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | RGD:1307880 | 6480464 | bisphenol A results in decreased expression of B4GALT4 mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | RGD:1317330 | 6480464 | bisphenol A results in decreased methylation of B4GALT4 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of B4GALT4 mRNA | CTD | PMID:34585602 | bisphenol A | increases methylation | ISO | RGD:1307880 | 6480464 | bisphenol A results in increased methylation of B4GALT4 gene | CTD | PMID:28505145 | cadmium dichloride | decreases methylation | ISO | RGD:1307880 | 6480464 | Cadmium Chloride results in decreased methylation of B4GALT4 promoter | CTD | PMID:22457795 | cadmium dichloride | increases expression | ISO | RGD:1307880 | 6480464 | Cadmium Chloride results in increased expression of B4GALT4 mRNA | CTD | PMID:33453195 | carbamazepine | affects expression | ISO | RGD:1317330 | 6480464 | Carbamazepine affects the expression of B4GALT4 mRNA | CTD | PMID:25979313 | chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of B4GALT4 mRNA | CTD | PMID:32715474 | copper(II) sulfate | decreases expression | ISO | RGD:1317330 | 6480464 | Copper Sulfate results in decreased expression of B4GALT4 mRNA | CTD | PMID:19549813 | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos, Crocidolite results in decreased expression of B4GALT4 mRNA | CTD | PMID:29279043 | diazinon | increases methylation | ISO | RGD:1317330 | 6480464 | Diazinon results in increased methylation of B4GALT4 gene | CTD | PMID:22964155 | dorsomorphin | multiple interactions | ISO | RGD:1317330 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of B4GALT4 mRNA | CTD | PMID:25629700 | folic acid | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of B4GALT4 mRNA | CTD | PMID:22206623 | furan | increases expression | ISO | RGD:1307880 | 6480464 | furan results in increased expression of B4GALT4 mRNA | CTD | PMID:27387713 | gallic acid | decreases expression | ISO | RGD:1317330 | 6480464 | Gallic Acid results in decreased expression of B4GALT4 mRNA | CTD | PMID:34408198 | gentamycin | decreases expression | ISO | RGD:1307880 | 6480464 | Gentamicins results in decreased expression of B4GALT4 mRNA | CTD | PMID:33387578 | ivermectin | decreases expression | ISO | RGD:1317330 | 6480464 | Ivermectin results in decreased expression of B4GALT4 protein | CTD | PMID:32959892 | methylmercury chloride | decreases expression | ISO | RGD:1317330 | 6480464 | methylmercuric chloride results in decreased expression of B4GALT4 mRNA | CTD | PMID:23179753, PMID:28001369 | methylphenidate | decreases expression | EXP | | 6480464 | Methylphenidate results in decreased expression of B4GALT4 mRNA | CTD | PMID:22470460 | N-methyl-4-phenylpyridinium | increases expression | ISO | RGD:1307880 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of B4GALT4 mRNA | CTD | PMID:28801915 | ozone | multiple interactions | ISO | RGD:1317330 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B4GALT4 mRNA more ... | CTD | PMID:32699268 | paracetamol | decreases expression | ISO | RGD:1307880 | 6480464 | Acetaminophen results in decreased expression of B4GALT4 mRNA | CTD | PMID:33387578 | phenylmercury acetate | decreases expression | ISO | RGD:1317330 | 6480464 | Phenylmercuric Acetate results in decreased expression of B4GALT4 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1317330 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B4GALT4 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | ISO | RGD:1317330 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of B4GALT4 mRNA | CTD | PMID:19710929 | quercetin | decreases expression | ISO | RGD:1317330 | 6480464 | Quercetin results in decreased expression of B4GALT4 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | RGD:1317330 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | testosterone enanthate | affects expression | ISO | RGD:1317330 | 6480464 | testosterone enanthate affects the expression of B4GALT4 mRNA | CTD | PMID:17440010 | tremolite asbestos | decreases expression | EXP | | 6480464 | tremolite results in decreased expression of B4GALT4 mRNA | CTD | PMID:29279043 | Tributyltin oxide | increases expression | EXP | | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of B4GALT4 mRNA | CTD | PMID:25270620 | trichostatin A | decreases expression | ISO | RGD:1317330 | 6480464 | trichostatin A results in decreased expression of B4GALT4 mRNA | CTD | PMID:24935251, PMID:26272509 | trichostatin A | multiple interactions | ISO | RGD:1317330 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B4GALT4 mRNA | CTD | PMID:27188386 | triptonide | decreases expression | EXP | | 6480464 | triptonide results in decreased expression of B4GALT4 mRNA | CTD | PMID:33045310 | urethane | increases expression | ISO | RGD:1317330 | 6480464 | Urethane results in increased expression of B4GALT4 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | RGD:1317330 | 6480464 | Valproic Acid results in increased expression of B4GALT4 mRNA | CTD | PMID:19101580 | valproic acid | affects expression | ISO | RGD:1317330 | 6480464 | Valproic Acid affects the expression of B4GALT4 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | RGD:1317330 | 6480464 | Valproic Acid results in decreased expression of B4GALT4 mRNA | CTD | PMID:24383497, PMID:26272509 | valproic acid | multiple interactions | ISO | RGD:1317330 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B4GALT4 mRNA | CTD | PMID:27188386 | |